, Latest global cancer data, 2018.
, Institut National du Cancer, 2019.
Cancer statistics, CA Cancer J Clin, 2014. ,
, CA Cancer J Clin, vol.64, issue.1, pp.9-29, 2014.
The biology of cancer, Garland Science, 2014. ,
An overview of epithelio-mesenchymal transformation, Acta Anat (Basel), vol.154, issue.1, pp.8-20, 1995. ,
The ins and outs of the epithelial to mesenchymal transition in health and disease, Annu Rev Cell Dev Biol, vol.27, pp.347-76, 2011. ,
Epithelial-mesenchymal transitions: from cell plasticity to concept elasticity, Curr Top Dev Biol, vol.112, pp.273-300, 2015. ,
Epithelial-mesenchymal transition, TGF-?, and osteopontin in wound healing and tissue remodeling after injury, J Burn Care Res, vol.33, issue.3, pp.311-319, 2012. ,
Epithelial-mesenchymal, mesenchymal-epithelial, and endothelial-mesenchymal transitions in malignant tumors: An update, World J Clin Cases, vol.3, issue.5, pp.393-404, 2015. ,
Epithelial-mesenchymal transition: a cancer researcher's conceptual friend and foe, Am J Pathol, vol.174, issue.5, pp.1588-93, 2009. ,
Tomic-Canic M. Epithelial-mesenchymal transition in tissue repair and fibrosis, Cell Tissue Res, vol.365, issue.3, pp.495-506, 2016. ,
Epithelium-mesenchyme interconversion as example of epithelial plasticity, APMIS, vol.101, issue.4, pp.257-68, 1993. ,
Mesenchyme to epithelium transition during development of the mammalian kidney tubule, Acta Anat (Basel), vol.156, issue.3, pp.187-201, 1996. ,
Epithelial plasticity: a common theme in embryonic and cancer cells, Science, vol.342, issue.6159, p.1234850, 2013. ,
Complex networks orchestrate epithelial-mesenchymal transitions, Nat Rev Mol Cell Biol, vol.7, issue.2, pp.131-173, 2006. ,
Molecular mechanisms of epithelial-mesenchymal transition, Nat Rev Mol Cell Biol, vol.15, issue.3, pp.178-96, 2014. ,
Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease, J Clin Invest, vol.119, issue.6, pp.1438-1487, 2009. ,
URL : https://hal.archives-ouvertes.fr/hal-02912722
Biomarkers for epithelial-mesenchymal transitions, J Clin Invest, vol.119, issue.6, pp.1429-1466, 2009. ,
Novel clinical therapeutics targeting the epithelial to mesenchymal transition, Clin Transl Med, vol.3, p.35, 2014. ,
Unraveling signalling cascades for the Snail family of transcription factors, Cell Signal, vol.17, issue.5, pp.535-582, 2005. ,
Genomic Instability Is Induced by Persistent Proliferation of Cells Undergoing Epithelial-to-Mesenchymal Transition, Cell Rep, vol.17, issue.10, pp.2632-2647, 2016. ,
The "seed and soil" hypothesis revisited, Lancet Oncol, vol.9, issue.8, p.808, 2008. ,
Variable beta-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment, Proc Natl Acad Sci U S A, vol.98, issue.18, pp.10356-61, 2001. ,
Bone morphogenic protein-7 induces mesenchymal to epithelial transition in adult renal fibroblasts and facilitates regeneration of injured kidney, J Biol Chem, vol.280, issue.9, pp.8094-100, 2004. ,
Mesenchymal-epithelial transition (MET) as a mechanism for metastatic colonisation in breast cancer, Cancer Metastasis Rev, vol.31, issue.3-4, pp.469-78, 2012. ,
Controversies around epithelial-mesenchymal plasticity in cancer metastasis, Nat Rev Cancer, vol.19, issue.12, pp.716-732, 2019. ,
EMT in cancer, Nat Rev Cancer, vol.18, issue.2, pp.128-134, 2018. ,
Epithelial-Mesenchymal Plasticity: A Central Regulator of Cancer Progression, Trends Cell Biol, vol.25, issue.11, pp.675-686, 2015. ,
Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition, Science, vol.339, issue.6119, pp.580-584, 2013. ,
Implications of the Hybrid Epithelial/Mesenchymal Phenotype in Metastasis. Front Oncol, vol.5, p.155, 2015. ,
Epithelial-type systemic breast carcinoma cells with a restricted mesenchymal transition are a major source of metastasis. Sci Adv, vol.5, p.4275, 2019. ,
Metabolic changes associated with tumor metastasis, part 1: tumor pH, glycolysis and the pentose phosphate pathway, Cell Mol Life Sci, vol.73, issue.7, pp.1333-1381, 2016. ,
TGF?-induced metabolic reprogramming during epithelial-to-mesenchymal transition in cancer, Cell Mol Life Sci, 2019. ,
Targeting the Metabolic Reprogramming That Controls Epithelial-to-Mesenchymal Transition in Aggressive Tumors. Front Oncol, vol.7, p.40, 2017. ,
Dlx-2 is implicated in TGF-?-and Wnt-induced epithelial-mesenchymal, glycolytic switch, and mitochondrial repression by Snail activation, Int J Oncol, vol.46, issue.4, pp.1768-80, 2015. ,
Twist promotes reprogramming of glucose metabolism in breast cancer cells through PI3K/AKT and p53 signaling pathways, Oncotarget, vol.6, issue.28, pp.25755-69, 2015. ,
Lysosomal protein turnover contributes to the acquisition of TGF?-1 induced invasive properties of mammary cancer cells, Mol Cancer, vol.14, p.39, 2015. ,
Fatty acid synthase mediates the epithelial-mesenchymal transition of breast cancer cells, Int J Biol Sci, vol.10, issue.2, pp.171-80, 2014. ,
Metabolic reprogramming during TGF?1-induced epithelial-to-mesenchymal transition, Oncogene, vol.34, issue.30, pp.3908-3924, 2015. ,
Histone deacetylase inhibitors induce epithelial-to-mesenchymal transition in prostate cancer cells, PLoS One, vol.7, issue.9, 2012. ,
Paracrine and autocrine signals induce and maintain mesenchymal and stem cell states in the breast, Cell, vol.145, issue.6, pp.926-966, 2011. ,
The consensus molecular subtypes of colorectal cancer, Nat Med, vol.21, issue.11, pp.1350-1356, 2015. ,
A colorectal cancer classification system that associates cellular phenotype and responses to therapy, Nat Med, vol.19, p.619, 2013. ,
Poor-prognosis colon cancer is defined by a molecularly distinct subtype and develops from serrated precursor lesions, Nat Med, vol.19, p.614, 2013. ,
Gene expression classification of colon cancer into molecular subtypes: characterization, validation, and prognostic value, PLoS Med, vol.10, p.1001453, 2013. ,
FLNA promotes chemoresistance of colorectal cancer through inducing epithelial-mesenchymal transition and smad2 signaling pathway, Am J Cancer Res, vol.10, issue.2, pp.403-423, 2020. ,
Tumor-derived tenascin-C promotes the epithelialmesenchymal transition in colorectal cancer cells, Anticancer Res, vol.33, issue.5, pp.1927-1961, 2013. ,
The clinical significance of circulating GPC1 positive exosomes and its regulative miRNAs in colon cancer patients, Oncotarget, vol.8, issue.60, pp.101189-101202, 2017. ,
,
, Signaling Axis Regulates the Epithelial-Mesenchymal Transition and Metastasis in Colorectal Cancer, Cell Physiol Biochem, vol.47, issue.2, pp.590-603, 2018.
Jun Baek M. Cyr61 expression is associated with prognosis in patients with colorectal cancer, BMC Cancer, vol.14, p.164, 2014. ,
The Crucial Role of CXCL8 and Its Receptors in Colorectal Liver Metastasis. Dis Markers, p.8023460, 2019. ,
, IL-8, a novel messenger to cross-link inflammation and tumor EMT via autocrine and paracrine pathways (Review), Int J Oncol, vol.48, issue.1, pp.5-12, 2016.
SERPINE1 as a cancer-promoting gene in gastric adenocarcinoma: facilitates tumour cell proliferation, migration, and invasion by regulating, EMT. J Chemother, issue.7-8, pp.408-418, 2019. ,
A Transcriptional Program for Detecting TGF?-Induced EMT in Cancer, Mol Cancer Res, vol.15, issue.5, pp.619-631, 2017. ,
THBS1 facilitates colorectal liver metastasis through enhancing epithelial-mesenchymal transition, Clin Transl Oncol, 2020. ,
Mechanisms and regulation of cholesterol homeostasis, Nat Rev Mol Cell Biol, vol.21, issue.4, pp.225-245, 2019. ,
The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor, Cell, vol.89, pp.331-340, 1997. ,
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver, J Clin Invest, vol.109, issue.9, pp.1125-1156, 2002. ,
Bao-liang Song 2 and Chenqi Xu Cholesterol metabolism in cancer: mechanisms and therapeutic opportunities, Nat Met, pp.132-141, 2020. ,
Mevalonate metabolism regulates Basal breast cancer stem cells and is a potential therapeutic target. Stem Cells, vol.30, pp.1327-1364, 2012. ,
URL : https://hal.archives-ouvertes.fr/hal-01431941
Signalling and non-caveolar rafts, Biochem Soc Trans, vol.29, pp.509-520, 2001. ,
Differential effects of pravastatin and simvastatin on the growth of tumor cells from different organ sites, PLoS ONE, 2011. ,
JAK2V617F-mediated signalling is dependent on lipid rafts and statins inhibit JAK2-V617F-dependent cell growth, Br J Haematol, vol.160, pp.177-87, 2013. ,
Profiling of estrogen up-and down-regulated gene expression in human breast cancer cells: insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype, Endocrinology, vol.144, issue.10, pp.4562-74, 2003. ,
Targeting estrogen receptor-? reduces adrenocortical cancer (ACC) cell growth in vitro and in vivo: potential therapeutic role of selective estrogen receptor modulators (SERMs) for ACC treatment, J Clin Endocrinol Metab, vol.97, issue.12, pp.2238-50, 2012. ,
A role for G-protein coupled estrogen receptor (GPER) in estrogeninduced carcinogenesis: Dysregulated glandular homeostasis, survival andmetastasis, J Steroid Biochem Mol Biol, vol.176, pp.38-48, 2018. ,
Cholesterol and Its Metabolites in Tumor Growth: Therapeutic Potential of Statins in Cancer Treatment. Front Endocrinol (Lausanne), vol.9, p.807, 2019. ,
Phospholipid Remodeling and Cholesterol Availability Regulate Intestinal Stemness and Tumorigenesis, Cell Stem Cell, vol.22, issue.2, pp.206-220, 2018. ,
Squalene Epoxidase Correlates E-Cadherin Expression and Overall Survival in Colorectal Cancer Patients: The Impact on Prognosis and Correlation to Clinicopathologic Features, J Clin Med, vol.8, issue.5, 2019. ,
TGF?-induced metabolic reprogramming during epithelial-to-mesenchymal transition in cancer, Cell Mol Life Sci, 2019. ,
A FASN-TGF-?1-FASN regulatory loop contributes to high EMT/metastatic potential of cisplatin-resistant non-small cell lung cancer, Oncotarget, vol.7, issue.34, pp.55543-55554, 2016. ,
Osthole suppresses hepatocyte growth factor (HGF)-induced epithelial-mesenchymal transition via repression of the c-Met/Akt/mTOR pathway in human breast cancer cells, J Agric Food Chem, vol.59, issue.17, pp.9683-90, 2011. ,
Targeting the Metabolic Reprogramming That Controls Epithelial-to-Mesenchymal Transition in Aggressive Tumors. Front Oncol, vol.7, p.40, 2017. ,
Metabolic reprogramming during TGF?1-induced epithelial-to-mesenchymal transition, Oncogene, vol.34, issue.30, pp.3908-3924, 2015. ,
PGC-1? mediates mitochondrial biogenesis and oxidative phosphorylation in cancer cells to promote metastasis, Nat Cell Biol, vol.16, issue.10, pp.1-15, 2014. ,
Cholesterol deprivation induces TGF? signaling to promote basal differentiation in pancreatic cancer, BioRxiv, 2019. ,
Clinical relevance of cholesterol homeostasis genes in colorectal cancer, Biochim Biophys Acta Mol Cell Biol Lipids, issue.10, pp.1314-1327, 1864. ,
Statins and Colorectal Cancer -A Systematic Review, Exp Clin Endocrinol Diabetes, vol.128, issue.4, pp.255-262, 2020. ,
The statin-low cholesterol-cancer conundrum, QJM, vol.105, issue.4, pp.383-391, 2012. ,
The role of cholesterol metabolism in cancer, Am J Cancer Res, vol.9, issue.2, pp.219-227, 2019. ,
Statins do not protect against cancer: quite the opposite, J Clin Oncol, 2015. ,
Statin use and reduced cancerrelated mortality, N Engl J Med, vol.368, issue.6, pp.576-583, 2013. ,
21) comme conséquence de l'induction de la transition épithéliale-mésenchymateuse : l'apparition d'erreurs de cytokinèse avec formation conséquente de cellules bi/polynucléées, 2016. ,
, ligne du haut) Apparition d'un grand nombre de cellules bi/polynucléées dans les cellules traitées (à droite) par rapport au cellules non traitée
, ligne du bas) Le pourcentage de cellules bi/polynucléées, après comptage sur 500 cellules non traitée (à gauche) et 500 cellules traitées (à droite)